RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 47 filers reported holding RECRO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361 | -56.2% | 770 | +2.7% | 0.00% | – |
| Q2 2023 | $825 | -77.8% | 750 | -76.0% | 0.00% | – |
| Q1 2023 | $3,720 | -15.3% | 3,126 | +6.0% | 0.00% | – |
| Q4 2022 | $4,393 | -12.1% | 2,948 | +0.3% | 0.00% | – |
| Q3 2022 | $5,000 | – | 2,939 | +432.4% | 0.00% | – |
| Q2 2022 | $0 | – | 552 | +17.7% | 0.00% | – |
| Q1 2022 | $0 | – | 469 | +0.6% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 466 | +0.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 465 | +2.0% | 0.00% | – |
| Q2 2021 | $1,000 | -98.2% | 456 | -97.7% | 0.00% | – |
| Q1 2021 | $57,000 | -6.6% | 20,147 | -4.8% | 0.00% | – |
| Q4 2020 | $61,000 | -31.5% | 21,152 | -50.2% | 0.00% | – |
| Q3 2020 | $89,000 | -75.1% | 42,488 | -45.9% | 0.00% | – |
| Q2 2020 | $357,000 | -79.6% | 78,495 | -63.3% | 0.00% | -100.0% |
| Q1 2020 | $1,747,000 | -8.5% | 213,698 | +105.1% | 0.00% | 0.0% |
| Q4 2019 | $1,910,000 | +216.7% | 104,189 | +91.6% | 0.00% | – |
| Q3 2019 | $603,000 | +14.6% | 54,375 | +5.1% | 0.00% | – |
| Q2 2019 | $526,000 | +114.7% | 51,754 | +23.7% | 0.00% | – |
| Q1 2019 | $245,000 | -74.7% | 41,837 | -69.4% | 0.00% | – |
| Q4 2018 | $970,000 | +0.3% | 136,553 | +0.4% | 0.00% | – |
| Q3 2018 | $967,000 | +10.0% | 135,991 | -22.3% | 0.00% | – |
| Q2 2018 | $879,000 | +3.9% | 175,092 | +127.9% | 0.00% | – |
| Q1 2018 | $846,000 | +73.0% | 76,832 | +45.4% | 0.00% | – |
| Q4 2017 | $489,000 | +122.3% | 52,848 | +115.6% | 0.00% | – |
| Q3 2017 | $220,000 | +81.8% | 24,508 | +42.5% | 0.00% | – |
| Q2 2017 | $121,000 | -19.3% | 17,200 | 0.0% | 0.00% | – |
| Q1 2017 | $150,000 | +11.1% | 17,200 | +3.0% | 0.00% | – |
| Q4 2016 | $135,000 | -51.1% | 16,700 | -46.5% | 0.00% | – |
| Q3 2016 | $276,000 | +73.6% | 31,200 | +56.0% | 0.00% | – |
| Q2 2016 | $159,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |